Assessment of Health Related Quality of Life in Cancer Patients Receiving Chemotherapy in Specialist Hospital, Jalingo, North-Eastern Nigeria.
No Thumbnail Available
Files
Date
2021-09
Journal Title
Journal ISSN
Volume Title
Publisher
Tehran University of Medical Sciences
Abstract
Background: This study aimed to assess Health-Related Quality of Life (HRQoL) in cancer
patients receiving chemotherapy in Specialist Hospital, Jalingo, North-Eastern Nigeria, in 2015.
Methods: A cross-sectional study was conducted on 218 cancer patients selected by
systematic random sampling method. The study data were collected using a modified
European Organization for Research and Treatment of Cancer QoL Questionnaire (EORTC
QLQ-C30 v. 3).
Results: Out of the 218 participants, 42(18.8%) had between 1 to 4 chemotherapy cycles,
while 86(39.4%) had 5 to 8 cycles and the remaining 91(41.7%) had 9 to 12 chemotherapy
cycles. There was a significant relationship between HRQoL and the number of chemotherapy
cycles received.
Conclusion: Encouraging cancer patients to complete a chemotherapy course plays an
essential role in the treatment outcome and the HRQoL in cancer patients undergoing
chemotherapy.
Description
Keywords
Anticancer, Quality of life, Cycles of chemotherapy, Nigeria
Citation
Giwa A., Sabum C., Giwa H. B., Jamiu M.O. (2021). Assessment of Health Related Quality of Life in Cancer Patients Receiving Chemotherapy in Specialist Hospital, Jalingo, North-Eastern Nigeria. Journal of Pharmacoeconomics and Pharmaceutical Management, 7 (3); 100-112.